Pfizer and Allergan terminate planned merger

8 April 2016 - Deborah Wilkes

Archived

Pfizer and Allergan have terminated their planned merger after the Department of Treasury and Inland Revenue Service in the US unveiled measures to curb corporate tax inversion deals. Pfizer also announced that it would now decide whether to separate its innovative and established businesses by the end of 2016.

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: